Shufro Rose & Co’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,200
Closed -$133K 319
2018
Q4
$133K Hold
1,200
0.01% 261
2018
Q3
$162K Hold
1,200
0.02% 268
2018
Q2
$166K Hold
1,200
0.02% 270
2018
Q1
$166K Sell
1,200
-83
-6% -$11.3K 0.02% 274
2017
Q4
$158K Hold
1,283
0.02% 264
2017
Q3
$175K Hold
1,283
0.02% 265
2017
Q2
$225K Hold
1,283
0.02% 238
2017
Q1
$154K Hold
1,283
0.02% 251
2016
Q4
$125K Hold
1,283
0.01% 250
2016
Q3
$121K Hold
1,283
0.01% 253
2016
Q2
$138K Sell
1,283
-50
-4% -$5.86K 0.02% 252
2016
Q1
$160K Hold
1,333
0.02% 247
2015
Q4
$158K Hold
1,333
0.02% 233
2015
Q3
$227K Sell
1,333
-67
-5% -$12.8K 0.03% 217
2015
Q2
$271K Sell
1,400
-650
-32% -$121K 0.03% 210
2015
Q1
$303K Sell
2,050
-83
-4% -$12.6K 0.03% 206
2014
Q4
$332K Hold
2,133
0.03% 193
2014
Q3
$305K Hold
2,133
0.03% 204
2014
Q2
$278K Hold
2,133
0.03% 209
2014
Q1
$261K Hold
2,133
0.03% 209
2013
Q4
$226K Hold
2,133
0.02% 226
2013
Q3
$239K Buy
2,133
+666
+45% +$75.6K 0.03% 207
2013
Q2
$165K Buy
+1,467
New +$179K 0.02% 235

Other funds holding SRGA

Shufro Rose & Co's SRGA Position: Q1 2019 in Review

Shufro Rose & Co sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2019, closing a stake of 1,200 shares — an estimated $133K sold.

Shufro Rose & Co first reported a position in SRGA in Q2 2013 and held it in 23 quarters. The position peaked at $332K in Q4 2014. 113 funds tracked by Wall St. Rank hold SRGA as of Q1 2019.

  • Shufro Rose & Co reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Shufro Rose & Co sold 1,200 Surgalign Holdings, Inc. Common Stock shares in Q1 2019, an estimated $133K.
  • Shufro Rose & Co first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • Shufro Rose & Co's Surgalign Holdings, Inc. Common Stock position peaked at $332K in Q4 2014.
  • 113 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2019.

Based on Shufro Rose & Co's 13F filing for Q1 2019, filed 3 May 2019.